Pioglitazone and PPAR-γ Modulating Treatment in Hypertensive and Type 2 Diabetic Patients After Ischemic Stroke: A National Cohort Study

Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-019-0979-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search